España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Cyclo Therapeutics
CYTH
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Cyclo Therapeutics (CYTH) Forecast
News
Earnings
Cyclo Therapeutics (CYTH) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cyclo Therapeutics (NASDAQ:CYTH) Stock
Cyclo Therapeutics Stock (NASDAQ: CYTH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 04, 2024
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Thursday, November 14, 2024
Cyclo Therapeutics Q3 EPS $(0.31) Misses $(0....
Benzinga Newsdesk
Thursday, September 05, 2024
Cyclo Therapeutics shares are trading higher ...
Benzinga Newsdesk
Cyclo Therapeutics Presents Preliminary Data ...
Benzinga Newsdesk
Tuesday, August 27, 2024
This Hershey Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
Avi Kapoor
Maxim Group Downgrades Cyclo Therapeutics to ...
Benzinga Newsdesk
Monday, August 26, 2024
Ascendiant Capital Maintains Buy on Cyclo The...
Benzinga Newsdesk
Friday, August 23, 2024
HC Wainwright & Co. Downgrades Cyclo Therapeu...
Benzinga Newsdesk
Thursday, August 22, 2024
Nasdaq Down Over 200 Points; Williams-Sonoma Shares Tumble After Q2 Results
Avi Kapoor
Gold Down Over 1%; US Initial Jobless Claims Increase
Avi Kapoor
Dow Jumps 100 Points; BJ's Wholesale Earnings Top Estimates
Avi Kapoor
Cyclo Therapeutics shares are trading lower a...
Benzinga Newsdesk
Rafael And Cyclo Therapeutics Have Agreed To ...
Benzinga Newsdesk
Friday, August 16, 2024
HC Wainwright & Co. Reiterates Buy on Cyclo T...
Benzinga Newsdesk
Thursday, August 15, 2024
Cyclo Therapeutics Q2 EPS $(0.21) Misses $(0....
Benzinga Newsdesk
Monday, July 29, 2024
Cyclo Therapeutics Receives Grant Notice From...
Benzinga Newsdesk
Monday, July 22, 2024
Cyclo Therapeutics Has Been Granted European ...
Benzinga Newsdesk
Friday, May 31, 2024
HC Wainwright & Co. Reiterates Buy on Cyclo T...
Benzinga Newsdesk
Thursday, May 30, 2024
Cyclo Therapeutics Completes Last Patient In ...
Benzinga Newsdesk
Thursday, May 16, 2024
Cyclo Therapeutics Q1 2024 GAAP EPS $(0.15) B...
Benzinga Newsdesk
Wednesday, May 01, 2024
HC Wainwright & Co. Initiates Coverage On Cyc...
Benzinga Newsdesk
Monday, April 22, 2024
Ascendiant Capital Initiates Coverage On Cycl...
Benzinga Newsdesk
Thursday, April 18, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, April 02, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Cyclo Therapeutics Receives Decision To Grant...
Benzinga Newsdesk
Monday, March 18, 2024
Cyclo Therapeutics FY23 EPS $(1.23) Up From $...
Benzinga Newsdesk
Thursday, March 14, 2024
Cyclo Therapeutics Announces Issuance Of U.S....
Benzinga Newsdesk
Wednesday, March 13, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, January 29, 2024
Cyclo Therapeutics Announces Allowance Of Pat...
Benzinga Newsdesk
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Thursday, December 28, 2023
Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Wednesday, December 27, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monday, December 18, 2023
Cyclo Therapeutics, Announced Outcome From It...
Benzinga Newsdesk
Wednesday, November 15, 2023
Cyclo Therapeutics Q3 EPS $(0.29) Up From $(0...
Benzinga Newsdesk
Wednesday, November 08, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Monday, November 06, 2023
Cyclo Therapeutics Has Received A Notice Of A...
Benzinga Newsdesk
Monday, October 23, 2023
Cyclo Therapeutics Announces Early Exercise Of Warrants By Board Members, Management And A Significant Shareholder Resulting In Cash Proceeds Of $2.4M
Happy Mohamed
Wednesday, September 27, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
Benzinga Insights
Maxim Group Upgrades Cyclo Therapeutics to Bu...
Benzinga Newsdesk
Thursday, September 21, 2023
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
Rare Disease Player Cyclo Therapeutics To Merge With Applied Molecular Transport
Vandana Singh
Cyclo Therapeutics shares are trading higher ...
Benzinga Newsdesk
Cyclo Therapeutics And Applied Molecular Tran...
Benzinga Newsdesk
Friday, September 08, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, August 15, 2023
Cyclo Therapeutics Ended The Quarter With ~$0.8M Of Cash. Subsequent To Quarter-End, The Company Generated Gross Proceeds Of $5M From The Sale Of Securities In Private Placements Of The Co's Securities
Happy Mohamed
Thursday, August 03, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Cyclo Therapeutics And This Other Penny Stock Insiders Are Buying
Lisa Levin
Wednesday, August 02, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, June 29, 2023
Cyclo Therapeutics Announces Publication Of Data From Phase 2 Clinical Study Of Trappsol Cyclo For The Treatment Of Niemann-Pick Disease Type C1
Happy Mohamed
Show More
